Go to the list of all blogs
Dem Sem's Avatar
published in Blogs
Feb 13, 2026
ConocoPhillips (COP) Q4 2025 Earnings Recap: Production Gains Cushion EPS Miss

ConocoPhillips (COP) Q4 2025 Earnings Recap: Production Gains Cushion EPS Miss

Key Takeaways

  • ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.

  • Net income fell to $1.4 billion ($1.17/share) from $2.3 billion ($1.90/share) in Q4 2024, primarily due to lower oil and gas prices.

  • Total production rose 6% year over year to 2,320 MBOED, with Lower 48 gains offsetting asset sales.

  • Cash from operations reached $4.3 billion; the company returned $2.1 billion to shareholders via dividends and buybacks.

  • Full-year 2025 production hit 2.375 MBOED, exceeding guidance, with $9 billion returned to shareholders.

  • 2026 guidance targets 2.33–2.36 MMBOED production, ~$12 billion capex, and $10.2 billion in operating costs.

Earnings Context and Why It Matters

ConocoPhillips’ Q4 results reflect the impact of softer commodity prices—WTI averaged below $60 per barrel in late 2025—while highlighting operational resilience. As a leading independent exploration and production company, COP’s execution provides a barometer for energy sector health. Investors closely monitor production efficiency, cost control, and capital returns, particularly following integration of the Marathon Oil acquisition. Strong full-year execution, including top-quartile dividend growth and $9 billion in shareholder returns, underscores the company’s focus on free cash flow generation amid volatile energy markets.

Reported Results vs. Expectations

Released on February 5, 2026, ConocoPhillips’ Q4 adjusted EPS of $1.02 missed the $1.08 consensus and declined sharply from $1.98 in Q4 2024. Reported EPS was $1.17, with net income at $1.4 billion versus $2.3 billion the prior year. Revenue totaled roughly $14.2 billion, slightly above the $14.05 billion consensus but below $14.7 billion a year earlier.

The earnings shortfall was largely due to lower realized prices of $42.46 per BOE, down 19% year over year, partially offset by higher volumes. Production rose to 2,320 MBOED, up 6% reported (2.6% lower organically after dispositions). Cash from operations reached $4.3 billion, with capex of $3.0 billion.

For the full year, adjusted EPS reached $6.16 on $19.9 billion in CFO, exceeding initial guidance across production, costs, and capital. Looking ahead, 2026 guidance targets 2.33–2.36 MMBOED production, ~$12 billion capex, and $10.2 billion in operating costs, incorporating over $1 billion in cost reductions from Marathon synergies and operational efficiencies.

Market Reaction and Investor Sentiment

Shares fell 2.7–3.8% in pre-market and early trading following the earnings release, reflecting investor disappointment over the EPS miss despite production outperformance and constructive guidance. Trading around $103–$104, the reaction highlighted sensitivity to price-driven earnings weakness, even as full-year operational execution and capital return commitments provided offsetting support. Short-term sentiment is cautious, with attention shifting to commodity price trends and integration of Marathon Oil assets.

Forward Outlook and Key Factors to Monitor

ConocoPhillips enters 2026 emphasizing capital discipline and cash generation. Key metrics include:

  • Production: 2.33–2.36 MMBOED, supported by efficiencies in the Lower 48 (>15% YoY gains) and Canadian projects like Surmont.

  • Capex & Costs: ~$12 billion in capital expenditures and $10.2 billion in operating costs, targeting $1+ billion in combined reductions via synergies and operational optimization.

  • Shareholder Returns: Maintaining 45% of CFO for dividends and buybacks, with a Q1 dividend of $0.84/share.

Catalysts include LNG developments (Qatar North Field East startup in H2 2026, Port Arthur LNG 10 MTPA offtake) and major project milestones like Willow first oil by 2029. Dispositions totaling $5 billion (following $3.2 billion in 2025) aim to reduce net debt. Reserves remain robust at 7.6 BBOE with 99% organic replacement.

Investors should track WTI price trends, well productivity in key U.S. basins (Permian, Delaware, Eagle Ford, Bakken), and free cash flow growth—projected $1 billion annually 2026–2028, totaling $7 billion by 2029 at $70 WTI. Geopolitical risks, inflation on capex, and global demand dynamics will continue to influence results. ConocoPhillips’ diversified portfolio across Alaska, Lower 48, and international assets positions it well to navigate market volatility.

The Trend Trader for Beginners: Strategy for Large Cap Stocks, 60 min, (TA) is a Tickeron AI trading bot tailored for large-cap stocks like COP.

Disclaimers and Limitations

Related Ticker: COP

Momentum Indicator for COP turns positive, indicating new upward trend

COP saw its Momentum Indicator move above the 0 level on July 08, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 89 similar instances where the indicator turned positive. In of the 89 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for COP just turned positive on July 08, 2026. Looking at past instances where COP's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

COP moved above its 50-day moving average on July 17, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for COP crossed bullishly above the 50-day moving average on July 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where COP advanced for three days, in of 341 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 312 cases where COP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for COP moved out of overbought territory on July 27, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 66 cases where COP's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where COP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

COP broke above its upper Bollinger Band on July 13, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. COP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.172) is normal, around the industry mean (7.201). P/E Ratio (19.498) is within average values for comparable stocks, (27.593). Projected Growth (PEG Ratio) (0.917) is also within normal values, averaging (4.366). Dividend Yield (0.029) settles around the average of (0.088) among similar stocks. P/S Ratio (2.453) is also within normal values, averaging (5.586).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are ConocoPhillips (NYSE:COP), Canadian Natural Resources Limited (NYSE:CNQ), EOG Resources (NYSE:EOG), Occidental Petroleum Corp (NYSE:OXY), Diamondback Energy (NASDAQ:FANG), Devon Energy Corp (NYSE:DVN), EQT Corp (NYSE:EQT), Expand Energy Corporation (NASDAQ:EXE), APA Corp (NASDAQ:APA), ANTERO RESOURCES Corp (NYSE:AR).

Industry description

The oil and gas production segment includes companies that specialize in exploration, development, and production of oil and natural gas. These companies are focused on upstream operations. Companies typically identify deposits, drill wells, and extract raw materials from underground. The industry also includes related services like rig operations, feasibility studies, machinery rentals etc. Several operators in this industry work with various types of contractors such as engineering procurement and construction contractors, as well as with joint-venture partners and oil field service companies. Oil and gas often involves large fixed costs of production; so, declining crude oil prices, for example, is a potential negative for this industry. Conoco Phillips, EOG Resources, Inc. and Pioneer Natural Resources Company are some examples of companies operating in this space.

Market Cap

The average market capitalization across the Oil & Gas Production Industry is 9.9B. The market cap for tickers in the group ranges from 3.28K to 140.15B. COP holds the highest valuation in this group at 140.15B. The lowest valued company is PSTRQ at 3.28K.

High and low price notable news

The average weekly price growth across all stocks in the Oil & Gas Production Industry was -1%. For the same Industry, the average monthly price growth was 5%, and the average quarterly price growth was 1%. GLND experienced the highest price growth at 22%, while PED experienced the biggest fall at -7%.

Volume

The average weekly volume growth across all stocks in the Oil & Gas Production Industry was -7%. For the same stocks of the Industry, the average monthly volume growth was 2% and the average quarterly volume growth was -16%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 49
Price Growth Rating: 52
SMR Rating: 74
Profit Risk Rating: 74
Seasonality Score: 1 (-100 ... +100)
View a ticker or compare two or three
COP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a producer of wholesales oil and natural gas

Industry OilGasProduction

Profile
Details
Industry
Oil And Gas Production
Address
925 North Eldridge Parkway
Phone
+1 281 293-1000
Employees
9900
Web
https://www.conocophillips.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
ConocoPhillips (COP) Q4 2025 Earnings Recap: Production Gains Cushion EPS Miss